CLINICAL TRIALS PROFILE FOR ALOSETRON HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for alosetron hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00067457 ↗ | Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy | Completed | GlaxoSmithKline | Phase 3 | 2003-06-01 | The purpose of this study is to compare the safety and effectiveness of as needed versus fixed dosing of an investigational medication for women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy. |
NCT00067561 ↗ | Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy | Completed | GlaxoSmithKline | Phase 3 | 2003-06-01 | The purpose of this study is to compare the safety and effectiveness of different doses of an investigational medication in women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy. |
NCT00130741 ↗ | Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS) | Completed | Hadassah Medical Organization | Phase 1 | 2005-07-01 | This is an 8-week double-blind, placebo-controlled, randomized, parallel-group study with an additional two week baseline observation period to evaluate the safety of combination herbal therapy (CHT) versus placebo and short and long-term efficacy in terms of improved IBS, overall quality of life (QOL) and symptomatology. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for alosetron hydrochloride
Condition Name
Clinical Trial Locations for alosetron hydrochloride
Trials by Country
Clinical Trial Progress for alosetron hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for alosetron hydrochloride
Sponsor Name